Recent trends and future directions in human immunodeficiency virus-associated cancer

Abstract

Malignancies, including the 3 that are part of the definition of the acquired immunodeficiency syndrome (AIDS) (Kaposi sarcoma [KS], non-Hodgkin lymphoma [NHL], and cervical cancer) as well as certain non-AIDS-defining cancers, cause significant morbidity and an estimated 33% of the deaths reported among patients infected with the human immunodeficiency virus (HIV). The US Multicenter AIDS Cohort Study (MACS) analysis highlighted several interesting and important trends in AIDS-defining and non-AIDS-defining cancers among individuals infected with HIV. Copyright © 2010 American Cancer Society.